Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601830-25-000166
Filing Date
2025-11-05
Accepted
2025-11-05 06:40:25
Documents
86
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rxrx-20250930.htm   iXBRL 10-Q 1162065
2 EX-31.1 exhibit311-q0325.htm EX-31.1 7597
3 EX-31.2 exhibit312-q0325.htm EX-31.2 7569
4 EX-32.1 exhibit321-q0325.htm EX-32.1 3994
10 GRAPHIC rxrx-20250930_g1.jpg GRAPHIC 211127
11 GRAPHIC rxrx-20250930_g2.jpg GRAPHIC 218414
  Complete submission text file 0001601830-25-000166.txt   8365310

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20250930.xsd EX-101.SCH 59879
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rxrx-20250930_cal.xml EX-101.CAL 89383
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rxrx-20250930_def.xml EX-101.DEF 302344
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20250930_lab.xml EX-101.LAB 736574
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20250930_pre.xml EX-101.PRE 511041
89 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20250930_htm.xml XML 911893
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40323 | Film No.: 251451649
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)